Abiopharma

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

BioRestorative Announces Closing of $5.0 Million Public Offering

ResMed Inc. Daily Stock Update

ICON PUBLIC LIMITED COMPANY INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

SC 13G/A (Amended Statement of Ownership) SEC Filing

QURE Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against uniQure N.V.